Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $397,750 - $523,647
9,882 New
9,882 $410,000
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $342,705 - $408,941
7,069 New
7,069 $363,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gunn & CO Investment Management, Inc. Portfolio

Follow Gunn & CO Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gunn & CO Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gunn & CO Investment Management, Inc. with notifications on news.